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Abstract
The activation process of secretory or membrane-bound zinc enzymes is thought to be a highly coordinated process
involving zinc transport, trafficking, transfer and coordination. We have previously shown that secretory and membrane-
bound zinc enzymes are activated in the early secretory pathway (ESP) via zinc-loading by the zinc transporter 5 (ZnT5)-
ZnT6 hetero-complex and ZnT7 homo-complex (zinc transport complexes). However, how other proteins conducting zinc
metabolism affect the activation of these enzymes remains unknown. Here, we investigated this issue by disruption and re-
expression of genes known to be involved in cytoplasmic zinc metabolism, using a zinc enzyme, tissue non-specific alkaline
phosphatase (TNAP), as a reporter. We found that TNAP activity was significantly reduced in cells deficient in ZnT1,
Metallothionein (MT) and ZnT4 genes (ZnT12/2MT2/2ZnT42/2 cells), in spite of increased cytosolic zinc levels. The reduced
TNAP activity in ZnT12/2MT2/2ZnT42/2 cells was not restored when cytosolic zinc levels were normalized to levels
comparable with those of wild-type cells, but was reversely restored by extreme zinc supplementation via zinc-loading by
the zinc transport complexes. Moreover, the reduced TNAP activity was adequately restored by re-expression of mammalian
counterparts of ZnT1, MT and ZnT4, but not by zinc transport-incompetent mutants of ZnT1 and ZnT4. In ZnT12/2MT2/2
ZnT42/2 cells, the secretory pathway normally operates. These findings suggest that cooperative zinc handling of ZnT1, MT
and ZnT4 in the cytoplasm is required for full activation of TNAP in the ESP, and present clear evidence that the activation
process of zinc enzymes is elaborately controlled.
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Introduction
Of all transition metals, zinc is the most widely used catalytic
and structural factor in proteins [1,2]. Zinc proteomics predicts
that approximately 10% of proteins encoded in the human
genome have a motif that potentially binds to zinc [3,4]. Among
these proteins, approximately 1000 are enzymes, which are
involved in diverse physiological functions and can be classified
into six major classes [5]. Most zinc enzymes use zinc as a catalytic
component [4], and therefore zinc coordination (metalation)
following zinc transport, trafficking and transfer is fundamental
for enzyme activity. The molecular mechanism for this activation
process, however, remains unclear. Metallothionein (MT) has
been suggested to control the activation of cytoplasmic zinc
enzymes [6] and to play a zinc chaperoning role in in vitro studies
[2,7]. All zinc transport proteins, including zinc transporters
(ZnTs) and ZRT/IRT-related proteins (ZIPs), would potentially
be involved in enzyme activation via zinc transport across the cell
membrane [8,9]. However, at present there is little direct
evidence.
Secretory and membrane-bound zinc enzymes, such as matrix
metalloproteinases, angiotensin-converting enzymes [10], A disin-
tegrin and metalloproteinase (ADAM) family proteins [11], and
alkaline phosphatase [12], are thought to become functional by
incorporating zinc in the early secretory pathway (ESP) before
reaching their final destination. Thus, zinc transport into the
lumen of the ESP is one of the crucial steps for enzyme activation
[9]. Compared with the well-known activation process of secretory
cuproenzymes by Atox1-ATP7A/ATP7B pathways [13–15],
understanding of the activation process of secretory and
membrane-bound zinc enzymes has been less clear. We have
previously shown that the ZnT5-ZnT6 hetero-complex and ZnT7
homo-complex (zinc transport complexes) are employed as zinc
entry routes into the ESP [16,17]. We have also shown that the
zinc transport complexes are indispensable for the activation of
secretory and membrane-bound zinc enzymes by converting them
PLOS ONE | www.plosone.org 1 October 2013 | Volume 8 | Issue 10 | e77445
from the apo to the holo form using tissue non-specific alkaline
phosphatase (TNAP) as a reporter enzyme [18]. However, how
other proteins involved in cellular zinc metabolism affect this
activation process remains unknown [19].
Here, we examined the TNAP activation process by establishing
a series of cells deficient in genes encoding molecules known to be
involved in cytoplasmic zinc metabolism. Specifically, we disrupt-
ed the ZnT1, MT and ZnT4 genes in the cells, whose products play
pivotal roles in the maintenance of cellular zinc homeostasis
[8,15,20] via regulatory mechanisms called ‘zinc buffering’ and
‘muffling’ [21,22]. Using these deficient cells, we show that ZnT1,
MT and ZnT4 contribute to full activation of TNAP in the ESP,
upstream of the zinc transport complexes.
Materials and Methods
Cell culture and transient transfection
Chicken B lymphocyte-derived DT40 cells were maintained in
RPMI 1640 (Nacalai Tesque, Kyoto, Japan) supplemented with
10% (v/v) heat-inactivated fetal calf serum (FCS; Multiser, Trace
Scientific, Melbourne, Australia), 1% (v/v) chicken serum
(Invitrogen, Carlsbad, CA, USA) and 50 mM 2-mercaptoethanol
(Sigma, St. Louis, MO, USA) at 39.5uC as previously described
[23]. Zinc-deficient medium was prepared using fetal calf and
chicken serum treated with Chelex-100 resin as described
previously [24]. To evaluate cell viability against extracellular
high zinc, the cells were cultured in the presence of 50–80 mM
ZnSO4 for 72 h. The numbers of viable cells, judged by exclusion
of trypan blue, were then counted and relative viability was
determined as previously described [25]. For transient transfec-
tion, circular plasmids (20 mg) were electroporated into cells
(56106 cells) as described previously [26].
Plasmid construction
The ,12-kb chicken MT (cMT) genes were amplified with
gene-specific primers by KOD-FX polymerase (TOYOBO,
Osaka, Japan) using DT40 genomic DNA as a template. The
long or short arm was PCR-amplified and subcloned downstream
or upstream of the drug selection marker cassettes, including drug-
resistant genes (Bsr or HisD) flanked by mutant loxP sites. These
targeting vectors were designed to disrupt both cMT1 and cMT2,
which are ,2 kb apart (Fig. S1). MT1 and MT2 were assigned as
described elsewhere [27]. Plasmids to express epitope-tagged
human ZnT1 (hZnT1), hZnT2, hZnT4, hZnT5, hZnT6, hZnT7
and mouse Mt-I (mMt-I) were constructed by inserting each
cDNA into pA-Puro, pA-Zeocin, pA-Ecogpt or pA-Neo vectors
[18]. Introduction of mutation into hZnT1 or hZnT4 cDNA was
carried out by the two-step PCR method, and amplified cDNAs
were sequenced in both directions. All plasmids were linearized
with appropriate restriction enzymes prior to electroporation for
establishing the stable transfectant. To construct the secretory
Cypridina luciferase expression plasmid for transient transfection
study, chicken b-actin promoter was inserted into the multiple
cloning site of pMCS-Cypridina Luc (Thermo Scientific, Waltham,
MA, USA). Construction of MT-I-Luc was as previously described
[28].
Generation of mutant cells and stable transfectants
The experimental strategy and targeting vectors used are shown
in Fig. S1. ZnT12/2 and ZnT42/2 were established as described
previously [18]. To obtain MT2/2 cells, wild-type (WT) DT40
cells were transfected sequentially with cMT-Bsr and cMT-HisD
targeting constructs. To generate ZnT12/2MT2/2 and ZnT12/2
MT2/2ZnT42/2 cells, the drug selection marker cassettes in
ZnT12/2 cells or ZnT12/2MT2/2 cells were excised according to
methods described previously [16]. Briefly, these cells stably
harboring pANMerCreMer plasmid were cultured for 2 days in
the presence of 200 nM 4-hydroxytamoxifen (Sigma), which
translocates MerCreMer protein (estrogen receptor-Cre recombi-
nase fusion protein) into the nucleus, thereby recombining DNA at
mutant loxP sites. Excision of the drug selection marker cassettes
was confirmed by loss of drug resistance. The established cells
were transfected sequentially with other targeting vectors de-
scribed in Fig. S1.
Measurement of TNAP activity, luciferase activities and
determination of zinc contents
TNAP activity was measured as previously described [17]. In
this study, calf intestine alkaline phosphatase (Promega, Madison,
WI, USA) was used to make a standard curve. Therefore, units of
TNAP activity were altered to be approximately 50-fold lower
than those in our previous study [23]. The activities of firefly and
renilla luciferase were measured using a dual-luciferase reporter
assay system (Promega) as described previously [26]. Firefly
luciferase activity was divided by renilla luciferase activity for
normalization of transfection efficiency. The activity of secretory
Cypridina luciferase in the spent medium was measured using
Pierce Cypridina Luciferase Glow Assay Kit (Thermo Scientific).
Zinc content in cells was determined using an inductive coupled
plasma mass spectrometer (Agilent7500ce, Agilent Technologies,
Hachioji, Japan), as described previously [29].
RT-PCR
Total RNA was isolated from harvested cells using Sepasol I
(Nacalai Tesque). Reverse transcription was performed using a
ReverTra Ace (TOYOBO), and PCR was performed using KOD-
FX (TOYOBO). Information on PCR primers and conditions
used are listed in Table S1.
Immunoblotting
Immunoblotting was performed as described previously [23].
The following antibodies were used: anti-FLAG M2 (Sigma;
1:2000 dilution), anti-FLAG tag antibody (anti-DDDDK; MBL,
Nagoya, Japan; 1:3000), anti-HA HA-11 (COVANCE, Emery-
ville, CA, USA; 1:3000), anti-MT (Dako, Glostrup, Denmark;
1:3000), anti-tubulin (Sigma; 1:10000) and anti-calnexin (Stress-
gen, Ann Arbor, MI, USA; 1:2000). For detection of MT, some
modifications were performed as described elsewhere [30].
Immobilon Western Chemiluminescent HRP Substrates (Milli-
pore, Billerica, MA, USA) or SuperSignal West Femto Maximum
Sensitivity Substrate (Pierce, Rockford, IL, USA) were used for
detection. The fluoroimage was obtained using a LAS1000 plus
image analyzer (Fujifilm, Tokyo, Japan).
Immunofluorescence staining
Immunostaining for FLAG-hZnT1 and hZnT4-HA expressed
in the cells was performed as previously described [18]. Briefly, the
cells were stained with anti-HA antibody (1:3000; COVANCE) or
anti-FLAG tag antibody (anti-DDDDK; 1:3000; MBL) followed
by Alexa 488-conjugated goat anti-rabbit IgG (1:3000; Molecular
Probes, Eugene, OR, USA), or followed by Alexa 594-conjugated
goat anti-mouse IgG (1:3000; Molecular Probes). Immunostaining
for the surface IgM was performed with anti-chicken IgM
antibody M4 (1:400; Beckman Instruments, Inc., Fullerton, CA,
USA), followed by Alexa 594-conjugated goat anti-mouse IgG
(1:400; Molecular Probes). The stained cells were observed under
a fluorescent microscope (Olympus, Tokyo, Japan). Images were
ZnT1, MT and ZnT4 Are Required for TNAP Activation
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analyzed using Adobe Photoshop Elements (Adobe Systems, Inc.,
San Jose, CA, USA).
Cell surface biotinylation
DT40 cells cultured in the fresh normal medium for 24 h were
washed twice with ice-cold phosphate buffered saline and then EZ-
Link, a Sulfo-NHS-SS-Biotin reagent (Pierce) was added to
biotinylated lysine residues exposed on the extracellular surface
of the plasma membrane. Biotinylated proteins were recovered
from the streptavidin-coupled beads in 6X SDS sample buffer and
then subjected to lectin blotting. Biotinylated proteins were
detected using the Streptavidin Biotin Complex Peroxidase Kit
(Nacalai Tesque). Lectin blotting was performed using biotin-
wheat germ agglutinin (WGA, Seikagaku Kogyo, Tokyo, Japan) as
described previously [26].
Statistical analyses
All data are depicted as mean 6 SD. Statistical significance was
determined by Student’s t test and accepted at p,0.01.
Results
Establishment and characterization of DT40 cells
deficient in cZnT1, cMT and cZnT4 genes
To investigate how proteins conducting cytoplasmic zinc
metabolism affect TNAP activation, we established DT40 cells
deficient in a series of chicken ZnT1 (cZnT1), cMT and/or cZnT4
genes (ZnT12/2, MT2/2, ZnT42/2, ZnT12/2MT2/2 and
ZnT12/2MT2/2ZnT42/2 cells) (Fig. S1). Because targeting
vectors for the cMT gene were designed to disrupt both cMT1
and cMT2 genes simultaneously, the MT2/2 cells established do
not express any MTs. DT40 cells do not express a functional
transcript of cZnT2 [18], although ZnT2 is known to contribute to
cytoplasmic zinc homeostasis [9,19,20], which precluded estab-
lishing ZnT22/2 cells in this study.
Consistent with previous literature on zinc-sensitive mutant
baby hamster kidney cell lines that neither express endogenous
MTs nor have functional ZnT1 [31], ZnT12/2MT2/2 cells
showed a zinc-sensitive phenotype to extracellular high zinc
(Fig. 1A). ZnT12/2MT2/2ZnT42/2 cells were more sensitive to
high zinc, and did not grow in the presence of 60 mM or more
ZnSO4 (Fig. 1A). An additional study using the MT-I luciferase
reporter, which is widely used to assess cytosolic zinc
levels, indicated increased luciferase activity in ZnT12/2MT2/2
ZnT42/2 cells compared with WT cells (Fig. 1B). These results
confirmed that ZnT12/2MT2/2ZnT42/2 cells have increased
cytosolic zinc levels compared with WT cells. The zinc-sensitive
phenotype of ZnT12/2MT2/2ZnT42/2 cells was reversed by re-
expressing hZnT1, mMt-I, or hZnT4, although the relative
contribution of hZnT4 was moderate (Table 1). The effects of re-
expression were also confirmed using the MT-I luciferase reporter
assay (data not shown). Taken together, loss of ZnT1, MT and
ZnT4 genes causes cytosolic zinc levels to increase in DT40 cells.
ZnT1, ZnT4 and MT are all involved in the activation
process of TNAP
TNAP activity was measured in ZnT12/2MT2/2ZnT42/2 cells
and other knockout cells established in this study. We first assumed
that zinc-dependent TNAP activity may be enhanced in these
cells because of the increase in cytosolic zinc levels. TNAP
activity in ZnT12/2 and ZnT42/2 cells remained unchanged, but
the activity in MT2/2 cells decreased slightly (Fig. 2A). Contrary
to our assumption, TNAP activity significantly decreased in
ZnT12/2MT2/2 cells, while that in ZnT12/2MT2/2ZnT42/2
cells decreased by approximately 90% when compared with that
in WT cells. TNAP mRNA expression levels were almost the same
among these cells (Fig. 2A).
We then confirmed that the decrease in TNAP activity was
attributed to the loss of ZnT1, MT and ZnT4. Single re-expression
of the human or mouse counterparts of these genes, specifically
hZnT1, mMt-I or hZnT4, in ZnT12/2MT2/2ZnT42/2 cells only
slightly restored the reduced TNAP activity, but re-expression of at
least two of the counterparts moderately restored activity. Re-
expression of all counterparts restored reduced TNAP activity to
that of WT cells (Fig. 2B). These results indicate that ZnT1, MT
and ZnT4 are all required for maintaining maximal activity of
TNAP.
The zinc transport complexes cannot fully operate for
TNAP activation in ZnT12/2MT2/2ZnT42/2 cells
We examined whether the zinc transport complexes, which are
indispensable for the activation of TNAP [9], can transport zinc
into the ESP to activate TNAP in ZnT12/2MT2/2ZnT42/2 cells.
Disruption of the cZnT5 gene in ZnT12/2MT2/2ZnT42/2 cells
markedly reduced TNAP activity to a level similar to that of
ZnT52ZnT62/2ZnT72/2 cells (termed TKO cells in our previous
studies [16,17]) (Fig. 2A and Fig. 3A, lane 3). Re-expression of
hZnT5 in ZnT12/2MT2/2ZnT42/2ZnT52 cells restored TNAP
activity to a level comparable to that in ZnT12/2MT2/2ZnT42/2
cells (Fig. 3A, lane 4), suggesting that residual TNAP activity was
caused via zinc transport into the ESP by the zinc transport
complexes. Moreover, we established ZnT12/2MT2/2ZnT42/2
cells stably over-expressing hZnT5 and hZnT6 simultaneously or
over-expressing hZnT7. However, TNAP activity was not
significantly enhanced and could not be restored to levels
comparable to that of WT cells in both cases (Fig. 3B), which
was in sharp contrast to the results in TKO cells stably expressing
hZnT5/hZnT6 or hZnT7, where similar levels of ZnTs expression
fully restored reduced TNAP activity [16–18]. Thus, the zinc
transport complexes cannot fully operate for TNAP activation in
ZnT12/2MT2/2ZnT42/2 cells.
The increased cytosolic zinc levels in ZnT12/2MT2/
2ZnT42/2 cells is not responsible for reduced TNAP
activity
We considered two possibilities that caused reduced TNAP
activity in ZnT12/2MT2/2ZnT42/2 cells; one is that the
increased cytosolic zinc levels may result in disturbance of
cytosolic zinc metabolism and thus negatively affect TNAP
activation by impairing the ability of the zinc transport complexes
to efficiently activate TNAP, and the other is that zinc handling by
ZnT1, MT and ZnT4 may be important for TNAP activation via
zinc-loading by the zinc transport complexes independently of the
cytosolic zinc levels. To explore the possibilities, we decreased the
cytosolic zinc levels in ZnT12/2MT2/2ZnT42/2 cells by exog-
enously expressing hZnT2, and measured TNAP activity, because
ZnT2 is known to have such activity by mobilizing zinc into the
vesicles where ZnT2 is localized [25,32,33]. As expected,
expression of hZnT2 made the cells resistant to high zinc toxicity
(Table 1), and decreased the cytosolic zinc levels in ZnT12/2
MT2/2ZnT42/2 cells, as shown by MT-I luciferase reporter
assays (Fig. 4A). The reduced TNAP activity, however, was not
significantly changed by expression of hZnT2 in ZnT12/2MT2/2
ZnT42/2 cells (Fig. 4B), suggesting that the increased cytosolic
zinc levels in ZnT12/2MT2/2ZnT42/2 cells is independent of the
reduction of TNAP activation. We also examined the effects of
ZnT1, MT and ZnT4 Are Required for TNAP Activation
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increased cytosolic zinc levels in ZnT12/2MT2/2ZnT42/2 cells
on TNAP activation by periodically measuring TNAP activity in
zinc-deficient cultures. The MT-I luciferase reporter assay showed
that zinc levels in ZnT12/2MT2/2ZnT42/2 cells cultured in zinc-
deficient conditions decreased to similar levels to that of WT cells
cultured in normal medium (time 0 h) (Fig. 4C, upper panel).
However, TNAP activity did not increase, but promptly decreased
during the culture (Fig. 4D, upper panel). These results strongly
suggest that it is unlikely that cytosolic zinc levels in ZnT12/2
MT2/2ZnT42/2 cells are crucial for TNAP activation.
While cytosolic zinc levels in ZnT12/2MT2/2ZnT42/2 cells
were enhanced compared with those in WT cells, the relative rate
of decrease in zinc levels during zinc-deficient culture was almost
the same between WT and ZnT12/2MT2/2ZnT42/2 cells
(Fig. 4C, lower panel). Similarly, the relative rate of decrease in
TNAP activity was almost the same between in both cells (Fig. 4D,
lower panel), although the absolute activities were markedly
different. In addition, no significant differences were found in
the rates of change in cellular zinc content and cell growth
between both cells during zinc-deficient culture (data not shown).
Thus, the cellular responses to maintain homeostasis of zinc
metabolism in response to zinc deficiency appear to function
normally in ZnT12/2MT2/2ZnT42/2 cells, although cytosolic
zinc levels markedly increased.
Extreme zinc supplementation restores TNAP activity in
ZnT12/2MT2/2ZnT42/2 cells
In the Atox1-ATP7A/ATP7B pathways [13–15], intracellular
copper increases in Atox1 knockout/knockdown cells do not result
in secretory cuproenzyme activation via ATP7A/ATP7B [34,35],
but copper supplementation can recover the activation [36,37].
Thus, we next examined the effects of zinc supplementation on
TNAP activity in ZnT12/2MT2/2ZnT42/2 cells. The reduced
TNAP activity in ZnT12/2MT2/2ZnT42/2 cells gradually
increased in the presence of zinc supplementation of up to
50 mM ZnSO4 (Fig. 5), which was the limiting concentration for
cells to grow (see Fig. 1A). This is in sharp contrast with that of
ZnT52ZnT62/2ZnT72/2 (TKO) cells, which could not be
restored by zinc supplementation, as shown in a previous study
[18]. Zinc supplementation also increased TNAP activity in both
ZnT12/2MT2/2ZnT42/2ZnT52 cells and ZnT12/2MT2/2
ZnT42/2ZnT52 cells stably expressing hZnT5. The differences
Figure 1. Cytosolic zinc levels are increased in ZnT12/2MT2/2ZnT42/2 cells. (A) Zinc sensitivity of DT40 cells deficient in cZnT1, cMT and/or
cZnT4 genes. Cells were grown in the presence of the indicated concentrations of ZnSO4 for 72 h and the number of living cells was counted (plotted
as a percentage of living cells at 40 mM ZnSO4 for each group of cells).N, wild-type (WT);#,MT2/2;%, ZnT12/2;g, ZnT12/2MT2/2;&, ZnT12/2MT2/2ZnT42/2 cells. Each value is the mean of two independent experiments. (B) Effects of zinc on MT-I luciferase reporter expression in WT cells and
ZnT12/2MT2/2ZnT42/2 cells. Both cell types were transiently transfected and cultured in the presence of 0, 25 or 50 mM ZnSO4 for 12 h. Relative
activity of luciferase is shown (the luciferase activity of WT cells cultured without ZnSO4 is defined as 1). Each value is the mean 6 SD of three
independent experiments (*P,0.01).
doi:10.1371/journal.pone.0077445.g001
Table 1. Restoration of resistance of ZnT12/2MT2/2ZnT42/2
cells by expression of the indicated genes against high zinc
toxicity.
ZnSO4 (mM)
Genes 50 60 70 80
- ++ - - -
FLAG-hZnT1 ++ ++ ++ ++
mMt-I ++ ++ ++ ++
hZnT4-HA ++ ++ + -
hZnT2-HA ++ ++ ++ ++
FLAG-hZnT1 H43A ++ - - -
hZnT4-HA H146A ++ - - -
The relative contribution of hZnT1, mMt-I or hZnT4 re-expression in ZnT12/2
MT2/2ZnT42/2 cells against zinc toxicity was determined by counting the
number of cells after 72 h exposure to the indicated concentrations of ZnSO4.
The relative contribution of exogenous expression of hZnT2 or mutant hZnT1 or
hZnT4 is also indicated. Relative values presented are evaluations of the
averages of three independent experiments. ++: growing to confluence; +: less
growth compared with ++ (20–50% relative to ++); -: not growing.
doi:10.1371/journal.pone.0077445.t001
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between their activities were caused by the presence or absence of
hZnT5 expression, which corresponds to the amount of TNAP
activity that is restored via zinc-loading by the ZnT5-ZnT6
hetero-complex in ZnT12/2MT2/2ZnT42/2 cells. Thus, the zinc
transport complexes can supply zinc to TNAP protein in the ESP
under conditions where cytosolic zinc levels are extremely
increased. These results strongly suggest that ZnT1, MT and
ZnT4 play a pivotal role in the activation process of TNAP
upstream of the zinc transport complexes.
Zinc transport activities of ZnT1 and ZnT4 are
indispensable for TNAP activation
Exogenous expression of hZnT2 did not significantly change
reduced TNAP activity in ZnT12/2MT2/2ZnT42/2 cells,
although it reversed cytosolic zinc levels (see Fig. 4A and B).
Moreover, hZnT2 expression did not significantly affect TNAP
activity restored by re-expression of all counterparts of ZnT1, MT
and ZnT4 in ZnT12/2MT2/2ZnT42/2 cells (Fig. 6A). These
results suggest that cooperative zinc handling of ZnT1, MT and
ZnT4 is crucial for full activation of TNAP, independently of
cytosolic zinc levels. To examine the notion in more depth, we
constructed H43A hZnT1 and H146A hZnT4 mutants, in which
the essential amino acids for zinc-binding in transmembrane
domains are substituted [18,19,38]. Loss of zinc transport activity
of both mutants was confirmed by the results that re-expression of
either mutant failed to reverse the zinc-sensitive phenotype
of ZnT12/2MT2/2ZnT42/2 cells (Table 1). We established
ZnT12/2MT2/2ZnT42/2 cells stably expressing either mutant
or both mutants, but the reduced TNAP activity never signifi-
cantly changed in any of these cases (Fig. 6B). Furthermore, co-
expression of both mutants with mMt-I in ZnT12/2MT2/2
ZnT42/2 cells did not result in significant increases in TNAP
activity, when compared with that in ZnT12/2MT2/2ZnT42/2
cells stably re-expressing all of the normal counterparts (Figs. 6C
and 2A). Immunofluorescence staining revealed that hZnT1 is
dominantly localized to the intracellular compartments/vesicles as
shown elsewhere [39,40], only partially overlapping with hZnT4
Figure 2. ZnT1, MT and ZnT4 are all involved in the activation process of TNAP. (A) TNAP activity decreased in DT40 cells deficient in
genes coding for cZnT1, cMT and/or cZnT4 (upper panel). TNAP activity of total cellular protein prepared from the indicated cells is expressed as the
mean 6 SD of three independent experiments (*P,0.01 vs. WT cells). Disruption of each gene was confirmed by RT-PCR using the appropriate
primers (lower panel). cMT2 expression is shown in duplicate (first and nested) to show significant or moderate induction of cMT2mRNA expression in
ZnT12/2 or ZnT42/2 cells. Confirmation of cTNAP expression is also shown. TKO; ZnT52ZnT62/2ZnT72/2 cells. (B) Re-expression of hZnT1, mMt-I and/
or hZnT4 restored TNAP activity in ZnT12/2MT2/2ZnT42/2 cells (upper panel). Expression of FLAG-hZnT1, mMt-I and hZnT4-HA was confirmed by
immunoblot analysis using total cellular or membrane proteins prepared from the indicated cells. Tubulin and calnexin (CNX) are shown as loading
controls (lower panels). TNAP activity is expressed as the mean 6 SD of three independent experiments (*P,0.01 vs. ZnT12/2MT2/2ZnT42/2 cells).
doi:10.1371/journal.pone.0077445.g002
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in ZnT12/2MT2/2ZnT42/2 cells, and the mutations of H43A in
hZnT1 and H146A in hZnT4 did not significantly change their
subcellular localization (Fig. 6D). These results indicate that zinc
handling by ZnT1 and ZnT4 in the cytoplasm is required for the
activation process of TNAP.
Homeostasis of the secretory pathway is not significantly
impaired in ZnT12/2MT2/2ZnT42/2 cells
Because the zinc transport complexes cannot fully operate for
TNAP activation in ZnT12/2MT2/2ZnT42/2 cells (see Fig. 3),
secretory homeostasis may be disturbed in the cells. Thus, we
investigated whether or not loss of ZnT1, MT and ZnT4 impaired
homeostasis of the secretory pathway. Because DT40 cells express
IgM on the cell surface [41], we first compared its expression in
WT and ZnT12/2MT2/2ZnT42/2 cells. Immunofluorescence
staining without permeabilization revealed that expression of IgM
was detected on the cell surface in both cells, and that fluorescence
intensities were almost the same between both cells (Fig. 7A). The
cell surface-localized proteins, which were biotinylated with
membrane-impermeable reagent, were also expressed to almost
the same levels between both cells (Fig. 7B). Lectin blotting using
WGA showed almost no difference between both cells (Fig. 7B),
which indicated that glycosylation in the secretory pathway was
unaffected in ZnT12/2MT2/2ZnT42/2 cells. Moreover, addi-
tional studies using secretory Cypridina luciferase confirmed normal
protein secretion in ZnT12/2MT2/2ZnT42/2 cells. The Cypridina
luciferase transiently transfected in WT and ZnT12/2MT2/2
ZnT42/2 cells revealed almost the same activities in their
spent medium (Fig. 7C). Taken together, homeostasis of the
secretory pathway is unlikely to be significantly impaired in
ZnT12/2MT2/2ZnT42/2 cells, most likely because the residual
activities of the zinc transport complexes are enough to maintain
it, although they are not enough to fully activate TNAP.
Figure 3. The zinc transport complexes cannot fully operate for TNAP activation in ZnT12/2MT2/2ZnT42/2 cells. (A) The residual TNAP
activity in ZnT12/2MT2/2ZnT42/2 cells was dependent on zinc-loading by the ZnT5-ZnT6 hetero-complex. TNAP activity of the total cellular protein
prepared from the indicated cells is expressed as the mean 6 SD of three independent experiments (*P,0.01 vs. ZnT12/2MT2/2ZnT42/2ZnT52/2
cells, upper panel). Expression of FLAG-hZnT5 in ZnT12/2MT2/2ZnT42/2ZnT52 cells was confirmed by immunoblot analysis using membrane proteins.
Calnexin (CNX) is shown as a loading control (lower panels). (B) Over-expression of hZnT5 and hZnT6 or hZnT7 failed to restore the reduced TNAP
activity in ZnT12/2MT2/2ZnT42/2 cells. TNAP activity of the total cellular protein prepared from the indicated cells is expressed as the mean 6 SD of
three independent experiments (*P,0.01 vs. WT cells, upper panel). Expression of FLAG-hZnT5 and HA-hZnT6 or HA-hZnT7 in ZnT12/2MT2/2ZnT42/2
cells was confirmed by immunoblot analysis as in A (lower panels).
doi:10.1371/journal.pone.0077445.g003
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Figure 4. Reduction of the cytosolic zinc levels in ZnT12/2MT2/2ZnT42/2 cells did not restore reduced TNAP activity. (A) Exogenous
expression of hZnT2 reduced the cytosolic zinc levels in ZnT12/2MT2/2ZnT42/2 cells. ZnT12/2MT2/2ZnT42/2 cells or ZnT12/2MT2/2ZnT42/2 cells
stably expressing hZnT2-HA were transiently transfected with MT-I luciferase as in Fig. 1B. Relative activity of luciferase is shown (the luciferase
activity of ZnT12/2MT2/2ZnT42/2 cells stably expressing hZnT2 cultured without ZnSO4 is defined as 1). Each value is the mean 6 SD of three
independent experiments (*P,0.01). (B) TNAP activity of the total cellular protein prepared from the indicated cells is expressed as the mean6 SD of
three independent experiments (N.S., not significant, upper panel). Expression of hZnT2 was confirmed by immunoblot analysis using total cellular
proteins. Tubulin is shown as a loading control (lower panels). (C) The change in cytosolic zinc levels in WT and ZnT12/2MT2/2ZnT42/2 cells during
zinc-deficient culture. Both cell lines were transiently transfected with MT-I luciferase, cultured in normal medium for 9 h, and then cultured in zinc-
deficient medium for the indicated period of time prior to measuring luciferase activity. (D) The change in TNAP activity in WT and ZnT12/2MT2/2
ZnT42/2 cells during zinc-deficient culture. Both cells cultured in normal medium were washed once and then cultured in zinc-deficient medium for
the indicated period. TNAP activity is expressed as the mean6 SD of three independent experiments. In the lower panels of C and D, relative rates of
change are plotted with values of WT or ZnT12/2MT2/2ZnT42/2 cells at time 0 h defined as 1. 1M4; ZnT12/2MT2/2ZnT42/2 cells.
doi:10.1371/journal.pone.0077445.g004
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Discussion
Zinc enzymes are estimated to constitute approximately 3% of
total cellular proteins [4,5], and thought to perform crucial
functions in various cellular and physiological processes [1,5].
However, very little information is available on how zinc is
trafficked and transferred to and then coordinated in zinc enzymes
and how that is controlled within the cells. The purpose of this
study was to investigate how proteins conducting cytoplasmic zinc
metabolism relate to TNAP activation in the ESP. We have shown
that cooperative functions of ZnT1, MT and ZnT4 are
indispensable for full activation of TNAP. Moreover, we found
that not cytosolic zinc levels but zinc handling by them is crucial
for this process. The zinc transport complexes cannot fully operate
to activate TNAP in ZnT12/2MT2/2ZnT42/2 cells except when
extreme zinc is supplemented. These results suggest that the
activation process of secretory and membrane-bound zinc
enzymes including TNAP are elaborately controlled before zinc
is mobilized into the ESP to be supplied to the enzymes. To our
knowledge, this is the first report describing molecular evidence of
a relationship between proteins conducting cytoplasmic zinc
metabolism and activation of secretory or membrane-bound zinc
enzymes.
The results of multiple experiments in this study clearly indicate
that zinc mobilization functions of ZnT1 and ZnT4 along with
MT functions are required for maximal TNAP activation. How do
these three proteins contribute to the TNAP activation process?
The reduced TNAP activity in ZnT12/2MT2/2ZnT42/2 cells
was almost unchanged by over-expressing the zinc transport
complexes (see Fig. 3). Moreover, the reduced activity was not
restored when increased cytosolic zinc levels were changed to
levels similar to those in WT cells (see Fig. 4). However, extremely
high zinc supplementation could restore the reduced activity (see
Fig. 5). These results suggest that cooperative functions of ZnT1,
MT and ZnT4 may lead to regulation that facilitates cytosolic zinc
delivery to the zinc transport complexes to supply zinc into the
lumen of the ESP. How zinc is delivered to zinc transporters has
been an unsolved question. Therefore, understanding the molec-
ular basis of zinc handling by ZnT1, MT and ZnT4 may provide
further clues.
Generally, ZnT1, MT and ZnT4 are thought to regulate
cytoplasmic zinc metabolism at different subcellular localizations
via different mechanisms; ZnT1 is mainly involved in cytosolic
zinc efflux at the plasma membrane, MT is involved in cytosolic
zinc chelation, and ZnT4 is involved in cytosolic zinc sequestration
in intracellular compartments [6,8,15,42,43]. Thus, one may ask
how they can work together in the TNAP activation process.
TNAP activity gradually decreased by disruption of ZnT1, MT
and ZnT4 genes, and re-expression of them gradually restored this
reduction in TNAP activity in a dose–dependent manner. These
results suggest that ZnT1, MT and ZnT4 contribute to the process
by their own functions and exclude the notion that they are
operative only when their functions merge. In our results,
immunofluorescence staining reveals the dominant intracellular
localization of hZnT1, only partially overlapping with hZnT4, in
ZnT12/2MT2/2ZnT42/cells (see Fig. 6D), which suggests that
ZnT1 localized to intracellular compartments/vesicles, not to
the plasma membrane, plays a critical role in the TNAP activation
process. Considering the direction of zinc transport by ZnT1
and ZnT4, which reversed the zinc-sensitive phenotype of
Figure 5. TNAP activity is restored by high zinc supplementation in ZnT12/2MT2/2ZnT42/2 cells. The indicated cells were cultured in
medium supplemented with 0, 25 or 50 mM ZnSO4 for 40 h. TNAP activity is the mean 6 SD of three independent experiments (N.S., not significant).
Note that TNAP activity in ZnT52ZnT62/2ZnT72/2 (TKO) cells was never restored.
doi:10.1371/journal.pone.0077445.g005
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Figure 6. Zinc transport activities of ZnT1 and ZnT4 are required for TNAP activation. (A) Expression of hZnT2 did not significantly affect
TNAP activity restored by re-expression of all of hZnT1, mMt-I and hZnT4 in ZnT12/2MT2/2ZnT42/2 cells (upper panel). Expression of FLAG-hZnT1,
mMt-I, hZnT4-HA and hZnT2-FLAG was confirmed by immunoblot analysis using total cellular or membrane proteins prepared from the indicated
cells (lower panels). (B) Re-expression of zinc transport-incompetent mutants hZnT1 (FLAG-hZnT1 H43A) or/and hZnT4 (hZnT4-HA H146A) failed to
significantly restore the reduced TNAP activity in ZnT12/2MT2/2ZnT42/2 cells (upper panel). Expression of FLAG-hZnT1 and hZnT4-HA mutants was
confirmed by immunoblot analysis (lower panels). (C) Expression of hZnT1 and hZnT4 mutants failed to adequately restore reduced TNAP activity,
even if mMt-I was expressed (upper panel). Expression of FLAG-hZnT1 H43A mutant, mMt-I and hZnT4-HA H146A mutant was confirmed by
immunoblot analysis (lower panels). In A–C, TNAP activity is expressed as the mean 6 SD of three independent experiments (*P,0.01, N.S., not
significant, upper panels), and tubulin and calnexin (CNX) are shown as loading controls (lower panels). (D) The subcellular localization of hZnT1,
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ZnT12/2MT2/2ZnT42/2 cells in this study (see Table 1), they
would transport zinc into the lumen of the intracellular
compartments/vesicles, from which zinc would be delivered to
the zinc transport complexes located in the ESP. One simple
potential model to explain the TNAP activation process is that
zinc mobilized by ZnT1 or ZnT4 into the compartments/vesicles
is redistributed to the cytosol by ZIP proteins or other zinc
transport proteins such as calcium channels, to be supplied to the
zinc transport complexes, and that MT would perform supportive
functions in this process. Human ZnT2 appears to reside in the
different intracellular compartments/vesicles from those where
ZnT1 and ZnT4 are localized (Fig. S2), suggesting that specific
compartmentalization of zinc by each ZnT transporter may be
critical for TNAP activation. The importance of zinc release out of
intracellular compartments by ZIP proteins and calcium channels
has been described in a number of studies [44–50], and a recent
report that absence of ZIP13 causes the reduction of TNAP
activity may support this notion [51]. The differences of re-
expression levels of ZnT1, MT and ZnT4 did not significantly
change the restoration rate of TNAP activation (data not shown),
which may also support it. Technical difficulty to determine the
precise intracellular localization of actual functional zinc trans-
porters is an obstacle to investigating this possibility in more detail.
Our strategy using DT40 cells has an advantage in addressing it,
because the cells express most of those proteins (ZnTs, MT, ZIPs
and calcium channels), which enables us to establish the cells
deficient in a combination of multiple genes among them.
This study highlights that TNAP activation is sophisticatedly
regulated by specific zinc transport systems including ZnT5,
ZnT6, ZnT7 in the ESP, and ZnT1, ZnT4 in the intracellular
compartments/vesicles, cooperating with MT. This kind of
regulation would be operative in the activation process of a
number of zinc enzymes in the ESP, because all of these proteins
are ubiquitously expressed [20,42,43] and because the strict
activation regulation of them is essential to control numerous
cellular events [1,5,8]. Clarification of TNAP activation mecha-
nism would contribute to determining the function of each protein
involved in zinc metabolism, as well as their interplay.
Supporting Information
Figure S1 Experimental strategy and targeting con-
structs. A, Strategy for disruption of all cZnT1, cMT, cZnT4
and cZnT5 genes. Because the cZnT5 gene is monosomic in DT40
cells, one targeting construct was used. B, Targeted disruption of
the cMT1 and cMT2 genes, which are ,2 kb apart on
chromosome 11. MT1 and MT2 are designed according to (27).
Closed boxes indicate exons deduced from the sizes of genomic
PCR fragments and the Chicken Genome Resources (http://
www.ncbi.nlm.nih.gov/projects/genome/guide/chicken/). The
HisD or Bsr drug resistant marker cassettes were flanked by
mutated loxP sites indicated by gray arrowheads. Two targeting
constructs, which are designed to disrupt exons encoding the open
reading frames of both cMT genes, are shown. Gray boxes
hZnT4 (upper panels) and their mutants (lower panels) expressed in ZnT12/2MT2/2ZnT42/2 cells. Nomarski, FLAG-hZnT1 (green), hZnT4-HA (red) and
the merged images are shown.
doi:10.1371/journal.pone.0077445.g006
Figure 7. Homeostasis of the secretory pathway is not significantly impaired in ZnT12/2MT2/2ZnT42/2 cells. (A) Surface IgM
expression was not impaired in ZnT12/2MT2/2ZnT42/2 cells. WT and ZnT12/2MT2/2ZnT42/2 cells were fixed and immunostained without
permeabilization. (B) The cell surface proteins biotinylated with membrane-impermeable reagent were almost the same between WT and ZnT12/2
MT2/2ZnT42/2 cells. Surface refers to the solubilized proteins captured using streptavidin beads, while input refers to the aliquot of the biotinylated
proteins before avidin capture (that is total cell lysate). In the surface panel, lectin blotting using WGA detects cell surface glycosylated proteins, and
CBB staining detects total cell surface proteins. 1M4; ZnT12/2MT2/2ZnT42/2 cells. (C) Secretory Cypridina luciferase expression was not significantly
different between WT and ZnT12/2MT2/2ZnT42/2 cells. Both cells transiently transfected with secretory Cypridina luciferase reporter were cultured
for 4 h after the medium change. Relative activity of Cypridina luciferase in the spent medium is shown (the luciferase activity/total cellular proteins in
WT cells is defined as 1). Each value is the mean 6 SD of three independent experiments (N.S., not significant).
doi:10.1371/journal.pone.0077445.g007
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indicate 59 and 39 probes used for confirming disruption of the
cMT genes. Southern blot analysis confirmed homologous
recombination at cMT loci (below left). Genomic DNA prepared
from the indicated genotypes (wild-type shown as WT, MT+/2
and MT2/2) was digested with EcoRI or BamHI, and hybridized
with the 59 or 39 probes shown above. RT-PCR analysis
indicated the absence of both cMT1 and cMT2 mRNA expression
in MT2/2 cells (below right). Southern blot and RT-PCR were
performed as described previously (23) and in the main text.
(EPS)
Figure S2 Human ZnT2 expressed in ZnT12/2MT2/2
ZnT42/2 cells is localized to different intracellular
compartments/vesicles from those where hZnT1 and
hZnT4 are located. FLAG-hZnT1and hZnT2-HA and the
merged image (upper panels), and hZnT2-FLAG and hZnT4-HA
and the merged image (lower panels), are shown.
(EPS)
Table S1 Primers used for RT-PCR analysis.
(DOC)
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